Amrutanjan Health Care Limited has informed the Exchange regarding 'Financial Results-Machine Readable Format'.
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amrutanjan Health Care reported audited FY2025-26 results with standalone revenue of ₹50,255.27 lakh, up 11.2% from ₹45,181.63 lakh in the prior year. Profit after tax grew 13.9% to ₹5,791.78 lakh versus ₹5,083.47 lakh. The Board recommended a final dividend of ₹2.90 per share (₹289.11 lakh total). Exceptional items include a one-time ₹760.50 lakh provision for revised lease rent on Tamil Nadu leasehold land (lost in court) and ₹125.17 lakh impact from new labour codes. The Auditor (B S R & Co. LLP) issued an unmodified opinion with no qualifications. The company also appointed Mr. Ramaswami Krishnan as Independent Director and launched Phase 2 of its ESOP scheme.
Revenue and profit grew double-digits year-on-year with healthy operating cash flow of ₹3,596.77 lakh. The exceptional items are non-recurring and do not undermine core business performance. The clean audit opinion and dividend declaration are positive signals for shareholders.